DC HEALTHCARE HOLDINGS BERHAD
KLSE (MYR): DCHCARE (0283)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.16
Today's Change
0.00 (0.00%)
Day's Change
0.00 - 0.00
Trading Volume
0
Changes
| Ann. Date | Date | Type | Name | Title | View |
|---|
Discussions
Be the first to like this. Showing 50 of 901 comments
all clear at 165, once new shop will start operating at q3 & can start to see some profit this quarter
2 months ago
The company will ensure that aesthetic healthcare is not just a service, but a necessity for enhancing wellbeing. Vry nice ~
2 months ago
Yupe, buying volume is slowly increasing and it will break through 20 cents eventually
2 months ago
Now this company has become very famous among Malaysians because of the advertisements they have done
2 months ago
Surface advertising only. Internal a lot of problems. Even their interviews are low standard, main problem many patients went to other aesthetic clinic, and complain Dr Chong quality, rather burn their left over package than going back. This is so bad
2 months ago
Yes. Saw all these naive comments without facts or research. Cannot tahan joined and gave my view. That’s called keyboard warrior FetcoveXX?
2 months ago
Jimmy7890 is from another aesthetic clinic which is not recognized by the Malaysia Book of Records ? 🤔 Why so jealous of DC healthcare getting interviewed?
2 months ago
hahaha sour comment spotted! DCHCARE doubling down on penang healthcare hub/tourism, see you above 0.20 soon
2 months ago
How can investors believe that after just one year the price fell cheaper than the IPO price?
Dr Chong pun cong jugak ke?
🤔🤔🤔
2 months ago
The company may use the funds saved from cancelling the RM70 million acquisition of I Bella Sdn Bhd for share buybacks 😁
2 months ago
@Travisbravis
big announcement soon, dr chong wont let us down
@marcelle5
Dr chong will push the share price up lah, ez tp 0.20
.........................................................................................................
Just after 1 year the market share price felt below IPO price..
also the technical chart stick all negative shown STRONG SELLLLLLLLLL...
All in just 1 yearrrrrrr...
huhuhuhu
1 month ago
Traders are often short-sighted. Look at Gen Z nowadays, the aesthetic industry is definitely booming
1 month ago
The new year is coming. People will go to the clinic to redeem aesthetic services 😁
1 month ago
Oops, still not 20cents yet, dropped further from my last comment. Good luck to Dr Chong paid fan 😄
1 month ago
Dow Jones
Dow Jones Industrial Average
42,740.42
-324.80
0.75%
Nasdaq
NASDAQ Composite
18,315.58
-187.10
1.01%
1 month ago
Target Price: RM0.200, RM0.220
Last closing price: RM0.180
Potential return: 11.1%, 22.2%
Support: RM0.175
Stop Loss: RM0.150
Huhuhuu
Still below IPO price..
1 month ago
Dow member McDonald’s
closed more than 5% lower. The Centers for Disease Control and Prevention said late Tuesday that an E. coli outbreak tied to the fast-food giant’s Quarter Pounder burgers has resulted in 10 hospitalizations and one death.
1 month ago
New IPO coming similar to DCHCARE..
METRO HEALTHCARE BERHD..
Same IPO price with DCH..
Going down also like DCH..
Huhuhu
3 weeks ago
DC Healthcare Holdings Berhad, has been actively expanding its operations by opening new branches across Malaysia. Their aggressive growth strategy has led to increased administrative and advertising expenses, contributing to recent financial losses. For instance, in the fourth quarter ended December 31, 2023, the company reported a net loss of RM1.07 million, despite achieving a revenue of RM17.57 million.
The share price has experienced a significant decline, closing at RM0.16 on November 8, 2024, marking a 69.23% drop over the past year. This downturn can be attributed to the financial losses and market concerns regarding the sustainability of its rapid expansion.
But I think the company's strategic initiatives, such as the establishment of new clinics in key locations like Johor Bahru and Ipoh, aim to tap into high-income markets and drive future revenue growth. Additionally, the implementation of an Employee Share Option Scheme (ESOS) is intended to align employee interests with company performance, potentially enhancing operational efficiency and profitability.
And I think, the share price may remain under pressure in the short term due to ongoing financial challenges and market scepticism. However, if the company's expansion efforts lead to increased market share and profitability, and if the ESOS successfully motivates employees to drive performance, there is potential for share price recovery in the medium to long term.
I think this will rebound sooner than later by 2nd Quarter 2025
2 weeks ago
Since its listing on Bursa, DCHCARE has encountered considerable financial challenges, reporting a net loss of RM18.49 million over the past twelve months and maintaining a negative profit margin of 32.82%. The stock has exhibited marked volatility, with weekly fluctuations averaging 10%, placing it among the top 25% of the most volatile stocks on the Malaysian market.
I believe the company’s strategy to expand its aesthetic services footprint—from 12 outlets in Q2 2023 to 17 in Q2 2024—alongside the launch of new product lines under the Ten Doctors brand and four additional outlets dedicated to slimming services, shows a strong commitment to growth. This increase, bringing the total to 21 outlets in Q2 2024 compared to the previous year’s 12, could create favourable prospects for financial recovery. However, the success of these initiatives will likely depend on broader market conditions and prevailing investor sentiment.
2 weeks ago
Post a Comment
Featured Posts
Latest Videos
Apps
Top Articles
1
Dragon Leong blog
2
save malaysia!
3
Follow Kim's Stockwatch!
4
5
save malaysia!
6
save malaysia!
7
Good Articles to Share
The 'Fast Money' traders share the stocks they are thankful for this holiday season
8
Good Articles to Share
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Hatiharihari
Place some buying orders at 16 cents for averaging 🙂
2 months ago